Merck ROA 2010-2024 | MKKGY
Current and historical return on assets (ROA) values for Merck (MKKGY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Merck ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2024-06-30 |
$2.84B |
$53.71B |
5.30% |
| 2024-03-31 |
$2.96B |
$53.75B |
5.53% |
| 2023-12-31 |
$3.06B |
$52.49B |
5.76% |
| 2023-09-30 |
$3.09B |
$54.32B |
5.86% |
| 2023-06-30 |
$3.22B |
$53.19B |
6.19% |
| 2023-03-31 |
$3.37B |
$52.21B |
6.53% |
| 2022-12-31 |
$3.51B |
$51.13B |
6.80% |
| 2022-09-30 |
$3.76B |
$51.30B |
7.21% |
| 2022-06-30 |
$3.73B |
$51.85B |
7.13% |
| 2022-03-31 |
$3.70B |
$51.89B |
7.08% |
| 2021-12-31 |
$3.62B |
$53.67B |
6.88% |
| 2021-09-30 |
$3.20B |
$51.69B |
6.27% |
| 2021-06-30 |
$3.25B |
$51.99B |
6.39% |
| 2021-03-31 |
$2.67B |
$52.92B |
5.35% |
| 2020-12-31 |
$2.27B |
$47.74B |
4.63% |
| 2020-09-30 |
$2.12B |
$50.54B |
4.29% |
| 2020-06-30 |
$1.56B |
$48.25B |
3.22% |
| 2020-03-31 |
$1.77B |
$49.36B |
3.72% |
| 2019-12-31 |
$1.48B |
$49.07B |
3.21% |
| 2019-09-30 |
$4.00B |
$46.78B |
8.95% |
| 2019-06-30 |
$4.02B |
$44.47B |
9.25% |
| 2019-03-31 |
$3.78B |
$43.98B |
8.80% |
| 2018-12-31 |
$3.99B |
$43.57B |
9.32% |
| 2018-09-30 |
$2.27B |
$41.56B |
5.41% |
| 2018-06-30 |
$2.63B |
$42.73B |
6.26% |
| 2018-03-31 |
$2.80B |
$43.24B |
6.75% |
| 2017-12-31 |
$2.94B |
$40.26B |
7.18% |
| 2017-09-30 |
$2.06B |
$42.11B |
4.98% |
| 2017-06-30 |
$1.82B |
$40.45B |
4.41% |
| 2017-03-31 |
$1.71B |
$40.87B |
4.11% |
| 2016-12-31 |
$1.80B |
$42.33B |
4.34% |
| 2016-09-30 |
$1.65B |
$41.00B |
3.98% |
| 2016-06-30 |
$1.55B |
$41.83B |
3.85% |
| 2016-03-31 |
$1.58B |
$41.01B |
4.15% |
| 2015-12-31 |
$1.25B |
$42.18B |
3.42% |
| 2015-09-30 |
$1.42B |
$35.90B |
4.11% |
| 2015-06-30 |
$1.35B |
$32.97B |
4.06% |
| 2015-03-31 |
$1.37B |
$34.72B |
4.25% |
| 2014-12-31 |
$1.50B |
$34.58B |
4.86% |
| 2014-09-30 |
$1.56B |
$30.15B |
5.39% |
| 2014-06-30 |
$1.68B |
$29.46B |
5.90% |
| 2014-03-31 |
$1.70B |
$28.79B |
6.00% |
| 2013-12-31 |
$1.60B |
$27.65B |
5.63% |
| 2013-09-30 |
$1.56B |
$28.25B |
5.51% |
| 2013-06-30 |
$1.35B |
$28.46B |
4.76% |
| 2013-03-31 |
$0.85B |
$29.00B |
3.01% |
| 2012-12-31 |
$0.73B |
$27.84B |
3.46% |
| 2012-09-30 |
$0.55B |
$27.86B |
2.55% |
| 2012-06-30 |
$0.64B |
$28.14B |
4.36% |
| 2012-03-31 |
$0.60B |
$0.00B |
3.83% |
| 2011-12-31 |
$0.84B |
$30.81B |
5.40% |
| 2011-09-30 |
$0.75B |
$0.00B |
9.55% |
| 2011-06-30 |
$0.70B |
$31.50B |
4.60% |
| 2011-03-31 |
$1.05B |
$0.00B |
14.16% |
| 2010-12-31 |
$0.84B |
$0.00B |
11.32% |
| 2010-09-30 |
$0.83B |
$29.68B |
11.23% |
| 2010-06-30 |
$0.77B |
$0.00B |
inf% |
| 2010-03-31 |
$0.69B |
$0.00B |
inf% |
| 2009-12-31 |
$0.51B |
$0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
